1. Home
  2. CMCT vs LYRA Comparison

CMCT vs LYRA Comparison

Compare CMCT & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCT
  • LYRA
  • Stock Information
  • Founded
  • CMCT 1993
  • LYRA 2005
  • Country
  • CMCT United States
  • LYRA United States
  • Employees
  • CMCT N/A
  • LYRA N/A
  • Industry
  • CMCT Real Estate Investment Trusts
  • LYRA Medical/Dental Instruments
  • Sector
  • CMCT Real Estate
  • LYRA Health Care
  • Exchange
  • CMCT Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • CMCT 12.9M
  • LYRA 13.5M
  • IPO Year
  • CMCT N/A
  • LYRA 2020
  • Fundamental
  • Price
  • CMCT $0.75
  • LYRA $0.19
  • Analyst Decision
  • CMCT
  • LYRA Buy
  • Analyst Count
  • CMCT 0
  • LYRA 5
  • Target Price
  • CMCT N/A
  • LYRA $4.50
  • AVG Volume (30 Days)
  • CMCT 1.3M
  • LYRA 1.9M
  • Earning Date
  • CMCT 11-08-2024
  • LYRA 11-12-2024
  • Dividend Yield
  • CMCT 22.38%
  • LYRA N/A
  • EPS Growth
  • CMCT N/A
  • LYRA N/A
  • EPS
  • CMCT N/A
  • LYRA N/A
  • Revenue
  • CMCT $124,599,000.00
  • LYRA $1,471,000.00
  • Revenue This Year
  • CMCT N/A
  • LYRA N/A
  • Revenue Next Year
  • CMCT N/A
  • LYRA N/A
  • P/E Ratio
  • CMCT N/A
  • LYRA N/A
  • Revenue Growth
  • CMCT 6.77
  • LYRA 3.37
  • 52 Week Low
  • CMCT $0.11
  • LYRA $0.16
  • 52 Week High
  • CMCT $4.40
  • LYRA $6.79
  • Technical
  • Relative Strength Index (RSI)
  • CMCT 54.56
  • LYRA 46.20
  • Support Level
  • CMCT $0.91
  • LYRA $0.18
  • Resistance Level
  • CMCT $1.06
  • LYRA $0.22
  • Average True Range (ATR)
  • CMCT 0.18
  • LYRA 0.02
  • MACD
  • CMCT 0.01
  • LYRA -0.00
  • Stochastic Oscillator
  • CMCT 33.83
  • LYRA 16.31

About CMCT Creative Media & Community Trust Corporation

Creative Media & Community Trust is formed to invest in, own, and operate Class A and creative office investments in improving urban communities throughout the United States. It operates through segments such as office, hotel and multifamily properties and lending. The Office segment includes rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment relates to operations of hotel properties whereas, the lending segment refers to income from the yield and other related fee income earned on its loans receivable. The lending segment includes income recognized from the sale of government guaranteed portion of loans receivable, income from the yield on its loans receivable and other related fee income earned.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: